These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 19343903)
1. Pharmacologic management of Parkinson's disease in long-term care residents: maintaining functionality to improve quality of life. Silver DE Director; 2007; 15(2):20-9. PubMed ID: 19343903 [No Abstract] [Full Text] [Related]
2. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Danisi F Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548 [TBL] [Abstract][Full Text] [Related]
3. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group. Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275 [TBL] [Abstract][Full Text] [Related]
4. Inhibitors of dopamine inactivating systems as antiparkinson drugs. Youdim MB Adv Neurol; 1990; 53():483-8. PubMed ID: 2239488 [No Abstract] [Full Text] [Related]
5. Parkinson's disease: focus on management alternatives. Young LR; Justice LN Am J Manag Care; 2000 Jan; 6(1):93-113; quiz 114-6. PubMed ID: 11009750 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of motor symptoms in Parkinson's disease]. Morís-De la Tassa G; Arias-Rodríguez M Rev Neurol; 2009 Jan; 48 Suppl 1():S27-31. PubMed ID: 19222012 [TBL] [Abstract][Full Text] [Related]
9. Drug selection and timing of initiation of treatment in early Parkinson's disease. Schapira AH; Olanow CW Ann Neurol; 2008 Dec; 64 Suppl 2():S47-55. PubMed ID: 19127579 [TBL] [Abstract][Full Text] [Related]
10. Quality of life in Polish patients with long-lasting Parkinson's disease. Zach M; Friedman A; Sławek J; Derejko M Mov Disord; 2004 Jun; 19(6):667-72. PubMed ID: 15197705 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors. Talati R; Reinhart K; Baker W; White CM; Coleman CI Parkinsonism Relat Disord; 2009 Aug; 15(7):500-5. PubMed ID: 19167259 [TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: diagnosis and treatment. Rao SS; Hofmann LA; Shakil A Am Fam Physician; 2006 Dec; 74(12):2046-54. PubMed ID: 17186710 [TBL] [Abstract][Full Text] [Related]
13. Treatment of levodopa-induced motor complications. Stocchi F; Tagliati M; Olanow CW Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681 [TBL] [Abstract][Full Text] [Related]
14. Falls in Parkinson's disease. Causes and impact on patients' quality of life. Michałowska M; Fiszer U; Krygowska-Wajs A; Owczarek K Funct Neurol; 2005; 20(4):163-8. PubMed ID: 16483454 [TBL] [Abstract][Full Text] [Related]
15. New drugs in the treatment of Parkinson's disease. An introduction. Bracco F Adv Neurol; 1996; 69():513-7. PubMed ID: 8615173 [No Abstract] [Full Text] [Related]
16. New drugs for Parkinson's disease. Med Lett Drugs Ther; 1976 Dec; 18(27):117-8. PubMed ID: 1004371 [No Abstract] [Full Text] [Related]
17. Clinical investigation of medicinal products in the treatment of Parkinson's disease (CPMP note for guidance). European Agency for Evaluation of Medicinal Products. Eur Neuropsychopharmacol; 1999 Sep; 9(5):443-9. PubMed ID: 10523052 [TBL] [Abstract][Full Text] [Related]